pyrazines has been researched along with oligonucleotides in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 9 (90.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhattacharya, N; Döhner, H; Führer, M; Idler, IS; Mertens, D; Sarno, A; Stilgenbauer, S; Zenz, T | 1 |
| Kopecky, K; Kucera, R; Miletin, M; Novakova, V; Zimcik, P | 1 |
| Arango, BA; Cohen, EE; Perez, CA; Raez, LE; Santos, ES | 1 |
| Asseline, U; Kleinmann, T; Lefoix, M; Mathis, G; Truffert, JC | 1 |
| Chang, LC; Chang, TC; Huang, FC; Kuo, MH; Lin, JJ; Tseng, TY; Wang, JM; Wang, ZF; Yen, SJ | 1 |
| Buchner, K; Eulberg, D; Facchetti, F; Ghobrial, IM; Klussmann, S; Kruschinski, A; Lonardi, S; Maasch, C; Maiso, P; Mishima, Y; Moschetta, M; Purschke, WG; Reagan, MR; Roccaro, AM; Rossi, G; Sacco, A; Ungari, M; Vater, A; Vonhoff, S; Zboralski, D; Zöllner, S | 1 |
| Hussar, DA | 1 |
| Ariyarathna, Y; Brown, EG; James, L; Juliano, RL; Mao, C; Ming, X; Suto, M; Tavares, F; Wang, L | 1 |
| Carey, KA; Farrar, MA; Jones, KJ; Kariyawasam, D | 1 |
| Campbell, T; Delgado, G; Galamay, D; Gately, M; Peoples, J; Weber, AL; Wong, S | 1 |
2 review(s) available for pyrazines and oligonucleotides
| Article | Year |
|---|---|
Novel molecular targeted therapies for refractory thyroid cancer.
Topics: Angiogenesis Inhibitors; Anilides; Antineoplastic Agents; Axitinib; Benzamides; Benzenesulfonates; Benzoquinones; Bibenzyls; Boronic Acids; Bortezomib; Depsipeptides; ErbB Receptors; Gefitinib; Histone Deacetylase Inhibitors; HSP90 Heat-Shock Proteins; Humans; Hydroxamic Acids; Imatinib Mesylate; Imidazoles; Indazoles; Indoles; Lactams, Macrocyclic; Lenalidomide; Niacinamide; Oligonucleotides; Phenylurea Compounds; Piperazines; Piperidines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-kit; Pyrazines; Pyridines; Pyrimidines; Pyrroles; Quinazolines; Quinolines; Receptor Protein-Tyrosine Kinases; Receptors, Vascular Endothelial Growth Factor; Sorafenib; Sulfonamides; Sunitinib; Thalidomide; Thyroid Neoplasms; Valproic Acid; Vorinostat | 2012 |
New and developing therapies in spinal muscular atrophy.
Topics: Cholestenones; Genetic Therapy; Humans; Imidazoles; Neuroprotective Agents; Oligonucleotides; Physical Therapy Modalities; Pyrazines; Respiration, Artificial; Spinal Muscular Atrophies of Childhood; Survival of Motor Neuron 1 Protein; Survival of Motor Neuron 2 Protein | 2018 |
8 other study(ies) available for pyrazines and oligonucleotides
| Article | Year |
|---|---|
High-throughput detection of nuclear factor-kappaB activity using a sensitive oligo-based chemiluminescent enzyme-linked immunosorbent assay.
Topics: Antineoplastic Agents; Boronic Acids; Bortezomib; CD40 Ligand; Cell Nucleus; Enzyme-Linked Immunosorbent Assay; HeLa Cells; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Luminescent Measurements; Lymphocytes; NF-kappa B; Oligonucleotides; Pyrazines; Tumor Necrosis Factor-alpha | 2010 |
Solid-phase synthesis of azaphthalocyanine-oligonucleotide conjugates and their evaluation as new dark quenchers of fluorescence.
Topics: Absorption; Base Sequence; Chromatography, High Pressure Liquid; Fluorescent Dyes; Oligonucleotide Probes; Oligonucleotides; Pyrazines; Pyrroles; Spectrometry, Fluorescence; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2010 |
Pyrazolo[1,5-a]-1,3,5-triazine C-nucleoside as deoxyadenosine analogue: synthesis, pairing, and resistance to hydrolysis.
Topics: Base Pairing; Biochemical Phenomena; Deoxyadenosines; Dinucleoside Phosphates; Hydrogen Bonding; Hydrolysis; Molecular Structure; Nucleic Acid Conformation; Nucleosides; Oligonucleotides; Pyrazines; Triazines | 2014 |
Inhibition of cancer cell migration and invasion through suppressing the Wnt1-mediating signal pathway by G-quadruplex structure stabilizers.
Topics: beta Catenin; Carbazoles; Cell Line, Tumor; Cell Movement; G-Quadruplexes; Gene Expression Regulation, Neoplastic; Humans; Immunoblotting; Inhibitor of Apoptosis Proteins; Matrix Metalloproteinase 7; Neoplasm Invasiveness; Oligonucleotides; Promoter Regions, Genetic; Pyrazines; Pyridinium Compounds; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Survivin; Wnt1 Protein | 2014 |
SDF-1 inhibition targets the bone marrow niche for cancer therapy.
Topics: Animals; Bone Marrow; Bone Marrow Neoplasms; Boronic Acids; Bortezomib; Chemokine CXCL12; Female; Gene Knockdown Techniques; Humans; Male; Mice; Mice, SCID; Multiple Myeloma; Neoplasm Metastasis; Oligonucleotides; Polyethylene Glycols; Pyrazines | 2014 |
New Drugs 2017, part 3.
Topics: Acetamides; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antitoxins; Bridged Bicyclo Compounds, Heterocyclic; Carbazoles; Chenodeoxycholic Acid; Drug Approval; Humans; Indoles; Morpholinos; Oligonucleotides; Piperidines; Polydeoxyribonucleotides; Pyrazines; Sulfonamides; United States; United States Food and Drug Administration | 2017 |
Structure-activity relationships and cellular mechanism of action of small molecules that enhance the delivery of oligonucleotides.
Topics: HeLa Cells; Humans; Intracellular Membranes; Oligonucleotides; Pyrazines; Pyridines; Structure-Activity Relationship | 2018 |
Synthesis and base-pairing properties of pyrazine nucleic acids.
Topics: Base Pairing; Models, Molecular; Nucleic Acid Conformation; Nucleic Acids; Oligonucleotides; Organophosphorus Compounds; Pyrazines; Pyrimidines; Stereoisomerism; Thymine | 2020 |